vs

Side-by-side financial comparison of Edwards Lifesciences (EW) and NetApp (NTAP). Click either name above to swap in a different company.

NetApp is the larger business by last-quarter revenue ($1.7B vs $1.6B, roughly 1.0× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 19.5%, a 3.6% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 4.4%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs 1.3%).

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

NetApp, Inc. is an American data infrastructure company that provides unified data storage, integrated data services, and cloud operations (CloudOps) solutions to enterprise customers. The company is based in San Jose, California. It has ranked in the Fortune 500 from 2012 to 2021. Founded in 1992 with an initial public offering in 1995, NetApp offers cloud data services for management of applications and data both online and physically.

EW vs NTAP — Head-to-Head

Bigger by revenue
NTAP
NTAP
1.0× larger
NTAP
$1.7B
$1.6B
EW
Growing faster (revenue YoY)
EW
EW
+12.3% gap
EW
16.7%
4.4%
NTAP
Higher net margin
EW
EW
3.6% more per $
EW
23.1%
19.5%
NTAP
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
1.3%
NTAP

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
EW
EW
NTAP
NTAP
Revenue
$1.6B
$1.7B
Net Profit
$380.7M
$334.0M
Gross Margin
78.0%
70.6%
Operating Margin
1.8%
25.3%
Net Margin
23.1%
19.5%
Revenue YoY
16.7%
4.4%
Net Profit YoY
6.8%
11.7%
EPS (diluted)
$0.66
$1.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EW
EW
NTAP
NTAP
Q1 26
$1.6B
$1.7B
Q4 25
$1.6B
$1.7B
Q3 25
$1.6B
$1.6B
Q2 25
$1.5B
$1.7B
Q1 25
$1.4B
$1.6B
Q4 24
$1.4B
$1.7B
Q3 24
$1.4B
$1.5B
Q2 24
$1.4B
$1.7B
Net Profit
EW
EW
NTAP
NTAP
Q1 26
$380.7M
$334.0M
Q4 25
$91.2M
$305.0M
Q3 25
$291.1M
$233.0M
Q2 25
$333.2M
$340.0M
Q1 25
$358.0M
$299.0M
Q4 24
$385.6M
$299.0M
Q3 24
$3.1B
$248.0M
Q2 24
$366.3M
$291.0M
Gross Margin
EW
EW
NTAP
NTAP
Q1 26
78.0%
70.6%
Q4 25
78.1%
72.0%
Q3 25
77.8%
70.4%
Q2 25
77.5%
68.9%
Q1 25
78.7%
69.8%
Q4 24
78.9%
71.0%
Q3 24
80.6%
71.3%
Q2 24
79.9%
70.5%
Operating Margin
EW
EW
NTAP
NTAP
Q1 26
1.8%
25.3%
Q4 25
9.6%
23.4%
Q3 25
19.8%
19.8%
Q2 25
26.8%
20.1%
Q1 25
27.9%
22.1%
Q4 24
22.6%
20.8%
Q3 24
25.9%
18.3%
Q2 24
26.8%
21.9%
Net Margin
EW
EW
NTAP
NTAP
Q1 26
23.1%
19.5%
Q4 25
5.8%
17.9%
Q3 25
18.7%
14.9%
Q2 25
21.7%
19.6%
Q1 25
25.3%
18.2%
Q4 24
27.8%
18.0%
Q3 24
226.7%
16.1%
Q2 24
26.7%
17.4%
EPS (diluted)
EW
EW
NTAP
NTAP
Q1 26
$0.66
$1.67
Q4 25
$0.16
$1.51
Q3 25
$0.50
$1.15
Q2 25
$0.56
$1.64
Q1 25
$0.61
$1.44
Q4 24
$0.65
$1.42
Q3 24
$5.13
$1.17
Q2 24
$0.61
$1.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EW
EW
NTAP
NTAP
Cash + ST InvestmentsLiquidity on hand
$3.0B
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$1.2B
Total Assets
$10.0B
Debt / EquityLower = less leverage
2.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EW
EW
NTAP
NTAP
Q1 26
$3.0B
Q4 25
$4.2B
$3.0B
Q3 25
$3.8B
$3.3B
Q2 25
$4.1B
$3.8B
Q1 25
$3.9B
$2.3B
Q4 24
$4.0B
$2.2B
Q3 24
$4.4B
$3.0B
Q2 24
$2.0B
$3.3B
Total Debt
EW
EW
NTAP
NTAP
Q1 26
$2.5B
Q4 25
$2.5B
Q3 25
$2.5B
Q2 25
$3.2B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
EW
EW
NTAP
NTAP
Q1 26
$1.2B
Q4 25
$10.3B
$986.0M
Q3 25
$10.2B
$975.0M
Q2 25
$10.5B
$1.0B
Q1 25
$10.1B
$995.0M
Q4 24
$10.0B
$892.0M
Q3 24
$9.5B
$929.0M
Q2 24
$7.4B
$1.1B
Total Assets
EW
EW
NTAP
NTAP
Q1 26
$10.0B
Q4 25
$13.7B
$9.6B
Q3 25
$13.3B
$9.7B
Q2 25
$13.5B
$10.8B
Q1 25
$13.0B
$9.0B
Q4 24
$13.1B
$9.0B
Q3 24
$13.0B
$9.3B
Q2 24
$10.1B
$9.9B
Debt / Equity
EW
EW
NTAP
NTAP
Q1 26
2.15×
Q4 25
2.52×
Q3 25
2.55×
Q2 25
3.11×
Q1 25
2.00×
Q4 24
2.23×
Q3 24
2.58×
Q2 24
2.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EW
EW
NTAP
NTAP
Operating Cash FlowLast quarter
$317.0M
Free Cash FlowOCF − Capex
$271.0M
FCF MarginFCF / Revenue
15.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.95×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EW
EW
NTAP
NTAP
Q1 26
$317.0M
Q4 25
$450.9M
$127.0M
Q3 25
$573.7M
$673.0M
Q2 25
$290.2M
Q1 25
$280.4M
$385.0M
Q4 24
$-127.5M
Q3 24
$351.8M
$341.0M
Q2 24
$371.5M
$613.0M
Free Cash Flow
EW
EW
NTAP
NTAP
Q1 26
$271.0M
Q4 25
$353.5M
$78.0M
Q3 25
$516.2M
$620.0M
Q2 25
$240.9M
Q1 25
$224.4M
$338.0M
Q4 24
$-177.3M
Q3 24
$299.9M
$300.0M
Q2 24
$286.1M
$567.0M
FCF Margin
EW
EW
NTAP
NTAP
Q1 26
15.8%
Q4 25
22.5%
4.6%
Q3 25
33.2%
39.8%
Q2 25
15.7%
Q1 25
15.9%
20.6%
Q4 24
-12.8%
Q3 24
22.1%
19.5%
Q2 24
20.9%
34.0%
Capex Intensity
EW
EW
NTAP
NTAP
Q1 26
Q4 25
6.2%
2.9%
Q3 25
3.7%
3.4%
Q2 25
3.2%
Q1 25
4.0%
2.9%
Q4 24
3.6%
Q3 24
3.8%
2.7%
Q2 24
6.2%
2.8%
Cash Conversion
EW
EW
NTAP
NTAP
Q1 26
0.95×
Q4 25
4.94×
0.42×
Q3 25
1.97×
2.89×
Q2 25
0.87×
Q1 25
0.78×
1.29×
Q4 24
-0.33×
Q3 24
0.11×
1.38×
Q2 24
1.01×
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EW
EW

Segment breakdown not available.

NTAP
NTAP

Services$927.0M54%
Product$786.0M46%

Related Comparisons